文献速递神经肿瘤

促红细胞生成素在脑胶质瘤中的作用:神经肿瘤学的新靶点

Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
PubMed 文献 · World Neurosurg · 2019-01-01

该研究检测人脑胶质瘤标本与大鼠9L细胞系种植模型中促红细胞生成素(EPO)及其受体(EPOR)的表达,并观察重组人EPO(rHuEPO)给药21天的影响。结果发现EPOR表达随病变恶性程度升高而增加,EPOR与Ki-67及血小板内皮细胞黏附分子表达呈显著正相关;rHuEPO组大鼠肿瘤播散明显大于生理盐水组。提示EPO/EPOR复合物可能参与高级别胶质瘤的侵袭行为。

要点

  • EPOR表达随胶质瘤恶性程度升高而增加,并与Ki-67、血小板内皮细胞黏附分子显著正相关。
  • 大鼠模型中每日给予rHuEPO共21天,肿瘤播散显著大于生理盐水组。
  • EPO/EPOR复合物可能促进恶性胶质瘤的侵袭与进展,需关注EPO制剂的潜在风险。

核心结论

  • EPO/EPOR复合物可能在高级别胶质瘤的侵袭行为中起重要作用。
  • rHuEPO处理大鼠肿瘤播散更大,提示EPO可能参与恶性胶质瘤的侵袭与进展。

研究设计与样本

  • 采用Western blotting与免疫组化分析人脑胶质瘤标本及实验诱导大鼠胶质瘤中EPO、EPOR、血小板内皮细胞黏附分子和Ki-67的表达。
  • 动物实验对接受9L细胞系种植的Fischer大鼠每日给予重组人EPO(rHuEPO)或生理盐水,共21天。

主要发现

  • 人与动物标本中,随病变呈更恶性模式,EPOR表达增加。
  • 低级别与高级别胶质瘤中,EPOR与Ki-67表达、EPOR与血小板内皮细胞黏附分子表达均呈显著正相关。
  • rHuEPO治疗大鼠的肿瘤播散显著大于生理盐水治疗大鼠。

临床怎么用

  • 胶质瘤患者使用EPO类制剂时应权衡其促红细胞生成作用与潜在促肿瘤侵袭风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Erythropoietin (EPO) is a cytokine primarily involved in the regulation of erythropoiesis. In response to hypoxia-ischemia, hypoxia-inducible factor 1 induces EPO production, which, in turn, inhibits apoptosis of erythroid progenitor cells. By the same mechanism and acting through other signaling pathways, EPO exerts neuroprotective effects. Increased resistance to hypoxia and decreased apoptosis are thought to be important mechanisms for tumor progression, including malignant glioma. Because recent studies have demonstrated that EPO and its receptor (EPOR) are expressed in several tumors and can promote tumor growth, in the present study, we investigated EPO and EPOR expression in human glioma and the effect of EPO administration in a rat model of glioma implantation. METHODS: Using Western blotting and immunohistochemical analysis, we examined the expression of EPO, EPOR, platelet endothelial cell adhesion molecule, and Ki-67 in human glioma specimens and experimentally induced glioma in rats. In the experimental setting, a daily dose of recombinant human EPO (rHuEPO) or saline solution were administered for 21 days in Fischer rats subjected to 9L cell line implantation. RESULTS: In both human and animal specimens, we found an increase in EPOR expression as long as the lesion presented with an increasing malignant pattern. A significant direct correlation was found between the expression of EPOR and Ki-67 and EPOR and platelet endothelial cell adhesion molecule in low- and high-grade gliomas. The rats treated with rHuEPO presented with significantly larger tumor spread compared with the saline-treated rats. CONCLUSIONS: The results of our study have shown that the EPO/EPOR complex might play a significant role in the aggressive behavior of high-grade gliomas. The larger tumor spread in rHuEPO-treated rats suggests a feasible role for EPO in the aggressiveness and progression of malignant glioma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Torregrossa F, Aguennouz M, La Torre D, et al. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology. World Neurosurg. 2019. PMID: 31658577. doi:10.1016/j.wneu.2019.06.221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。